{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:25:19Z","timestamp":1784309119263,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>C-reactive protein (CRP) is an acute-phase protein produced by the liver in response to infection and during chronic inflammatory disorders. Systemic inflammation is a major driver of cirrhosis progression from the compensated to the decompensated stage. Previous studies have shown that pentameric CRP (pCRP) to be a weak predictor of disease severity and prognosis in patients with decompensated hepatitis B cirrhosis, with it being only helpful for identifying patients with a higher short-term risk of death under certain conditions. Accumulating evidence indicates that pCRP dissociates to and acts primarily as the monomeric conformation (mCRP) at inflammatory loci, suggesting that mCRP may be a potentially superior disease marker with higher specificity and relevance to pathogenesis. However, it is unknown whether mCRP and anti-mCRP autoantibodies are associated with disease severity, or progression in decompensated hepatitis B cirrhosis. In this study, we evaluated the serum levels of mCRP and anti-mCRP autoantibodies in patients with decompensated cirrhosis of hepatitis B and their association with disease severity and theoretical prognosis. The results showed that patients with high mCRP and anti-mCRP autoantibody levels had more severe liver damage and that coagulation function was worse in patients with high anti-mCRP autoantibodies. Analysis of the correlation between pCRP, mCRP and anti-mCRP autoantibody levels with Model for End-Stage Liver Disease (MELD), Albumin-Bilirubin (ALBI), and Child\u2013Turcotte\u2013Pugh (CTP) prognostic scores showed that mCRP was the most strongly correlated with MELD score, followed by anti-mCRP autoantibodies; conversely, pCRP was not significantly correlated with prognostic score. Therefore, mCRP and anti-mCRP autoantibodies may be more advantageous clinical indicators than pCRP for evaluating the pathological state of decompensated hepatitis B cirrhosis.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1407768","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T05:40:59Z","timestamp":1717479659000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Monomeric C-reactive protein is associated with severity and prognosis of decompensated hepatitis B cirrhosis"],"prefix":"10.3389","volume":"15","author":[{"given":"Ning","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Ming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Geng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00050-4","article-title":"Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review","volume":"7","author":"Alberts","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Trepo","year":"2014","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic liver failure","volume":"382","author":"Arroyo","year":"2020","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.02.016","article-title":"Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection","volume":"77","author":"Montanari","year":"2022","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.52601\/bpr.2021.200024","article-title":"What do we know about IL-6 in COVID-19 so far","volume":"7","author":"Jingrui","year":"2021","journal-title":"Biophysics Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1038\/s41467-020-16092-0","article-title":"Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis","volume":"11","author":"An","year":"2020","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02013","article-title":"Abnormal innate immunity in acute-on-chronic liver failure: immunotargets for therapeutics","volume":"11","author":"Khanam","year":"2020","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jcmgh.2021.09.003","article-title":"C-reactive protein protects against acetaminophen-induced liver injury by preventing complement overactivation","volume":"13","author":"Li","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-030409-101305","article-title":"An integrated view of humoral innate immunity: pentraxins as a paradigm","volume":"28","author":"Bottazzi","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-013-8384-0","article-title":"C-reactive protein and the biology of disease","volume":"56","author":"Ansar","year":"2013","journal-title":"Immunol Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)74047-2","article-title":"Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis","volume":"267","author":"Agrawal","year":"1992","journal-title":"J Biol Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.152.11.5404","article-title":"Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis","volume":"152","author":"Agrawal","year":"1994","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.128.6.2745","article-title":"Complement-induced solubilization of C-reactive protein-pneumococcal C-polysaccharide precipitates: evidence for covalent binding of complement proteins to C-reactive protein and to pneumococcal C-polysaccharide","volume":"128","author":"Volanakis","year":"1982","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.007124","article-title":"Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy","volume":"130","author":"Thiele","year":"2014","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(83)90140-2","article-title":"Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium","volume":"20","author":"Potempa","year":"1983","journal-title":"Mol Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"14188","DOI":"10.1038\/ncomms14188","article-title":"Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites","volume":"8","author":"Braig","year":"2017","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.4049\/jimmunol.2200831","article-title":"C-reactive protein: the most familiar stranger","volume":"210","author":"Ji","year":"2023","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-021-00584-8","article-title":"Monomeric C reactive protein (mCRP) regulates inflammatory responses in human and mouse chondrocytes","volume":"101","author":"Ruiz-Fernandez","year":"2021","journal-title":"Lab Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1302\/2046-3758.123.BJR-2022-0223.R1","article-title":"Monomeric CRP regulates inflammatory responses in human intervertebral disc cells","volume":"12","author":"Ruiz-Fernandez","year":"2023","journal-title":"Bone Joint Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.52601\/bpr.2021.200045","article-title":"Mutual interaction of microbiota and host immunity during health and diseases","volume":"7","author":"Di","year":"2021","journal-title":"Biophysics Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.721887","article-title":"CRP enhances the innate killing mechanisms phagocytosis and ROS formation in a conformation and complement-dependent manner","volume":"12","author":"Zeller","year":"2021","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.125732","article-title":"Monomeric C-reactive protein decreases acetylated LDL uptake in human endothelial cells","volume":"55","author":"Schwedler","year":"2009","journal-title":"Clin Chem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"103073","DOI":"10.1016\/j.jaut.2023.103073","article-title":"Extracellular vesicles opsonized by monomeric C-reactive protein (CRP) are accessible as autoantigens in patients with systemic lupus erythematosus and associate with autoantibodies against CRP","volume":"139","author":"Karlsson","year":"2023","journal-title":"J Autoimmun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016070735","article-title":"Autoantibodies against C-reactive protein influence complement activation and clinical course in lupus nephritis","volume":"28","author":"Li","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.178.287","article-title":"Comparative study of C-reactive protein in chronic hepatitis B and chronic hepatitis C","volume":"178","author":"Shima","year":"1996","journal-title":"Tohoku J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-010-0098-7","article-title":"Circulating biomarkers and their possible role in pathogenesis of chronic hepatitis B and C viral infections","volume":"26","author":"Khan","year":"2011","journal-title":"Indian J Clin Biochem"},{"key":"B29","article-title":"Serum high-sensitivity C-reactive protein are associated with HBV replication, liver damage and fibrosis in patients with chronic hepatitis B","volume":"62","author":"Ma","year":"2015","journal-title":"Hepatogastroenterology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00511","article-title":"An ELISA assay for quantifying monomeric C-reactive protein in plasma","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2002.35927","article-title":"The new liver allocation system: Moving toward evidence-based transplantation policy","volume":"8","author":"Freeman","year":"2002","journal-title":"Liver Transplant"},{"key":"B33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2022.10.010","article-title":"Cholesterol-binding sequence is a key regulatory motif of cellular folding and conformational activation for C-reactive protein","volume":"152","author":"Lv","year":"2022","journal-title":"Mol Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.695023","article-title":"An intrinsically disordered motif mediates diverse actions of monomeric C-reactive protein","volume":"291","author":"Li","year":"2016","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.08.021","article-title":"On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites","volume":"74","author":"Caraceni","year":"2021","journal-title":"J Hepatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3201\/eid2305.161477","article-title":"Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China","volume":"23","author":"Cui","year":"2017","journal-title":"Emerging Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy181","article-title":"Matrix sieving-enforced retrograde transcytosis regulates tissue accumulation of C-reactive protein","volume":"115","author":"Li","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B40","article-title":"C-reactive protein and bacterial infection in cirrhosis","volume":"27","author":"Pieri","year":"2014","journal-title":"Ann Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.01.024","article-title":"Increased monomeric CRP levels in acute myocardial infarction: A possible new and specific biomarker for diagnosis and severity assessment of disease","volume":"239","author":"Wang","year":"2015","journal-title":"Atherosclerosis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.866379","article-title":"Monomeric C-reactive protein: current perspectives for utilization and inclusion as a prognostic indicator and therapeutic target","volume":"13","author":"Slevin","year":"2022","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.555318","article-title":"Topological localization of monomeric C-reactive protein determines proinflammatory endothelial cell responses","volume":"289","author":"Li","year":"2014","journal-title":"J Biol Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1407768\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T10:09:02Z","timestamp":1721383742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1407768\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2024.1407768"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1407768","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"article-number":"1407768"}}